| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | PGI HOLDING CORPORATION | 215 COLLEGE RD | PARAMUS | NJ | 07652-1400 | BERGEN | USA | R43MH121136 | Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders | 000 | 1 | NIH | 10/13/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $88,432 ) |
| | 2020 | 2020 | PGI HOLDING CORPORATION | 215 COLLEGE RD | PARAMUS | NJ | 07652-1400 | BERGEN | USA | R43MH121136 | Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders | 000 | 1 | NIH | 12/6/2019 | $88,432 |
|
| Issue Date FY: 2019 ( Subtotal = $449,973 ) |
| | 2019 | 2019 | PGI HOLDING CORPORATION | 215 COLLEGE RD | PARAMUS | NJ | 07652-1400 | BERGEN | USA | R43MH121136 | Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders | 000 | 1 | NIH | 7/12/2019 | $449,973 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2015 | PGI HOLDING CORPORATION | 765 OLD SAW MILL RIVER RD STE 104 | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 001 | 3 | NIH | 12/30/2016 | $0 |
| | 2017 | 2012 | PGI HOLDING CORPORATION | 765 OLD SAW MILL RIVER RD STE 104 | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 000 | 1 | NIH | 12/1/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $915,977 ) |
| | 2015 | 2015 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 000 | 3 | NIH | 7/16/2015 | $915,977 |
|
| Issue Date FY: 2014 ( Subtotal = $691,074 ) |
| | 2014 | 2014 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 001 | 2 | NIH | 9/25/2014 | $691,074 |
| | 2014 | 2012 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 000 | 1 | NIH | 1/30/2014 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $1,179,176 ) |
| | 2012 | 2012 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44DA035051 | Predictive Smoking Cessation Preclinical Battery | 000 | 1 | NIH | 9/10/2012 | $829,176 |
| | 2012 | 2012 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43MH088096 | ELTOPRAZINE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION ASSOC. WITH SCHIZOPHRENIA | 000 | 2 | NIH | 6/6/2012 | $350,000 |
|
| Issue Date FY: 2011 ( Subtotal = $350,000 ) |
| | 2011 | 2011 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43MH088096 | ELTOPRAZINE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION ASSOC. WITH SCHIZOPHRENIA | 000 | 1 | NIH | 7/18/2011 | $350,000 |
|
| Issue Date FY: 2010 ( Subtotal = $597,605 ) |
| | 2010 | 2010 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44MH070240 | HIGH THROUGHPUT IN VIVO DRUG DISCOVERY - PHASE II | 000 | 5 | NIH | 11/17/2009 | $450,000 |
| | 2010 | 2010 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43CA133985 | HDAC6-SELECTIVE INHIBITORS FOR PANCREATIC CANCER TREATMENT | 000 | 3 | NIH | 2/23/2010 | $147,605 |
| | 2010 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43NS061352 | NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY | 000 | 2 | NIH | 4/22/2010 | $0 |
| | 2010 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH083350 | PRODRUGS OF NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA | 000 | 2 | NIH | 1/25/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $1,144,294 ) |
| | 2009 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43CA133985 | HDAC6-SELECTIVE INHIBITORS FOR PANCREATIC CANCER TREATMENT | 000 | 2 | NIH | 9/11/2009 | $12,356 |
| | 2009 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43MH083350 | PRODRUGS OF NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA | 000 | 2 | NIH | 5/26/2009 | $300,539 |
| | 2009 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R43NS061352 | NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY | 000 | 2 | NIH | 2/24/2009 | $381,399 |
| | 2009 | 2009 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591-6702 | WESTCHESTER | USA | R44MH070240 | HIGH THROUGHPUT IN VIVO DRUG DISCOVERY - PHASE II | 000 | 4 | NIH | 11/10/2008 | $450,000 |
|
| Issue Date FY: 2008 ( Subtotal = $2,427,220 ) |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44MH070240 | HIGH THROUGHPUT IN VIVO DRUG DISCOVERY - PHASE II | 000 | 3 | NIH | 12/27/2007 | $450,000 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH078433 | PIPERIDINE-BASED COMPOUNDS AS THERAPEUTICS FOR NARCOLEPSY-CATAPLEXY | 000 | 3 | NIH | 6/26/2008 | $250,000 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43NS062437 | DEVELOPMENT OF GSK-3 BETA INHIBITORS FOR THE TREATMENT OF PARKINSON'S DISEASE | 000 | 3 | NIH | 6/19/2008 | $282,300 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43NS061352 | NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY | 000 | 1 | NIH | 7/21/2008 | $379,412 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43CA133985 | HDAC6-SELECTIVE INHIBITORS FOR PANCREATIC CANCER TREATMENT | 000 | 1 | NIH | 9/18/2008 | $206,721 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R41DA023291 | NICOTINIC LIGANDS AS SMOKING CESSATION AGENTS | 000 | 3 | NIH | 7/14/2008 | $288,900 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH083350 | PRODRUGS OF NAAG PEPTIDASE INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA | 000 | 1 | NIH | 6/11/2008 | $319,887 |
| | 2008 | 2008 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH075460 | HIGH THROUGHPUT BEHAVIORAL TESTING FOR NOVEL ANTIDEPRESSANTS | 000 | 2 | NIH | 7/19/2008 | $250,000 |
|
| Issue Date FY: 2007 ( Subtotal = $449,963 ) |
| | 2007 | 2007 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH076342 | HIGHER THROUGHPUT BEHAVIORAL SCREENING OF COGNITIVE ENHANCERS | 000 | 2 | NIH | 1/24/2007 | $199,963 |
| | 2007 | 2007 | PSYCHOGENICS INC | 765 OLD SAW MILL RIVER | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43MH075460 | HIGH THROUGHPUT BEHAVIORAL TESTING FOR NOVEL ANTIDEPRESSANTS | 000 | 1 | NIH | 7/31/2007 | $250,000 |
|
| Issue Date FY: 2006 ( Subtotal = $435,878 ) |
| | 2006 | 2006 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH076342 | HIGHER THROUGHPUT BEHAVIORAL SCREENING OF COGNITIVE ENHANCERS | 000 | 1 | NIH | 1/15/2006 | $200,000 |
| | 2006 | 2006 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH071041 | IN VIVO DRUG DISCOVERY FROM COMPOUND MIXTURES | 000 | 2 | NIH | 6/30/2006 | $235,878 |
|
| Issue Date FY: 2005 ( Subtotal = $732,298 ) |
| | 2005 | 2005 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH071041 | IN VIVO DRUG DISCOVERY FROM COMPOUND MIXTURES | 000 | 1 | NIH | 6/17/2005 | $232,298 |
| | 2005 | 2005 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH070240 | HIGH THROUGHPUT IN VIVO DRUG DISCOVERY-PHASE 1 | 000 | 2 | NIH | 5/16/2005 | $250,000 |
| | 2005 | 2005 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH070264 | ANIMAL MODELS OF SCHIZOPHRENIA: NRG-ERBB FUNCTION | 000 | 2 | NIH | 1/31/2005 | $250,000 |
|
| Issue Date FY: 2004 ( Subtotal = $1,080,710 ) (Continued on the next page) |
| | 2004 | 2004 | PSYCHOGENICS INC | 4 SKYLINE DRIVE | ELMSFORD | NY | 10532 | | USA | R43MH070264 | ANIMAL MODELS OF SCHIZOPHRENIA: NRG-ERBB FUNCTION | 000 | 1 | NIH | 2/13/2004 | $250,000 |
|
